To assess long-term drug survival and effectiveness in biological drug-naïve patients with rheumatoid arthritis (RA), starting infliximab as first treatment, in the period 2000-2009, comparing different calendar years.

Iannone, F., Salaffi, F., Marchesoni, A., Gorla, R., Atzeni, F., Govoni, M., Gremese, E., Lapadula, G., On Behalf Of Gisea Gruppo Italiano Di Studio Sulle Early Arthritides, A., Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years, <<CLINICAL AND EXPERIMENTAL RHEUMATOLOGY>>, 2015; 33 (4): 524-530 [http://hdl.handle.net/10807/72016]

Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years

Gremese, Elisa;
2015

Abstract

To assess long-term drug survival and effectiveness in biological drug-naïve patients with rheumatoid arthritis (RA), starting infliximab as first treatment, in the period 2000-2009, comparing different calendar years.
Inglese
Iannone, F., Salaffi, F., Marchesoni, A., Gorla, R., Atzeni, F., Govoni, M., Gremese, E., Lapadula, G., On Behalf Of Gisea Gruppo Italiano Di Studio Sulle Early Arthritides, A., Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years, <<CLINICAL AND EXPERIMENTAL RHEUMATOLOGY>>, 2015; 33 (4): 524-530 [http://hdl.handle.net/10807/72016]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/72016
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact